Indacaterol/mometasone

Indacaterol/Mometasone is a combination medication used in the treatment of asthma. It contains indacaterol, a long-acting beta-adrenoceptor agonist (LABA), and mometasone furoate, a corticosteroid.

Etymology

The name "Indacaterol" is derived from the components of the drug: "Inda" refers to the indole ring structure, "cater" refers to the catechol structure, and "ol" indicates that it is an alcohol. The name "Mometasone" is derived from the components of the drug: "Mome" refers to the mometasone furoate structure, and "one" indicates that it is a ketone.

Pharmacology

Indacaterol works by relaxing the muscles in the walls of the airways, opening them and making it easier to breathe. Mometasone furoate works by reducing inflammation in the lungs, which can make breathing difficult.

Clinical Use

Indacaterol/Mometasone is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. It is generally used when a patient's asthma is not well controlled with a different medication.

Side Effects

Common side effects of Indacaterol/Mometasone include headache, throat irritation, and upper respiratory tract infection. Serious side effects may include worsening asthma, pneumonia, and adrenal insufficiency.

Related Terms

• Long-acting beta-adrenoceptor agonist
• Corticosteroid
• Asthma
• Inflammation
• Adrenal insufficiency